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Abstract: This paper describes a molecular strategy to restore adhesion of cells to surfaces that otherwise
do not present ligands that can mediate adhesion. The approach is based on a carbonic anhydrase fusion
protein that binds benzenesulfonamides and that also includes the RGD peptide motif that can bind to
cell-surface integrin adhesion receptors. In this way, the fusion protein can bind to a monolayer that presents
the benzenesulfonamide ligand, thereby positioning the RGD peptide at the surface, where it can mediate
the adhesion and spreading of cells. This strategy may provide a general method for promoting the adhesion
of cells to non-natural surfaces or to defective biological matrices.
Introduction
Most cells are adherent and must attach and spread on a
protein matrix in order to survive and carry out their functions.
Most commonly, the integrin family of receptors mediates
adhesion by binding to peptides within the matrix. In this way,
the adhesion of cells to a given substrate can be promoted by
either modifying the latter with ligands for an endogenous
receptor or engineering the cell to introduce receptors that
recognize an epitope on the surface.
1-4 Both routes have been
explored for promoting tissue integration with medical devices
and for treating the blistering diseases caused by laminin and
collagen mutations that disrupt normal adhesion of the epidermis
and dermis.
5 An unexplored route to promote cell adhesion when
complementary receptors and ligands are not present would use
an adaptor protein that can simultaneously bind to the cell-
surface receptor and an epitope present on the substrate. In this
paper we demonstrate that this strategy can restore cell adhesion
to substrates that do not present ligands for the endogenous
receptors. Like adhesion to a normal matrix, the adaptor protein-
mediated adhesion is speciﬁc, and the polyvalent engagement
of receptors is able to sustain the mechanical forces applied by
the cell and support the assembly of a contractile cytoskeleton.
We use self-assembled monolayers (SAMs) that present
ligands against a background of tri(ethylene glycol) groups as
model substrates for cell adhesion. Previous work has shown
that monolayers that present the RGD peptide ligand support
the integrin-mediated adhesion and spreading of cells.
6 The
glycol groups are an important component of the monolayers,
as they prevent the nonspeciﬁc attachment of cells and therefore
ensure that adhesion is mediated only by the immobilized
ligand.
2 In the present work, we characterized the adhesion of
Chinese hamster ovary (CHO) cells on a monolayer presenting
a benezenesulfonamide ligand (Figure 1A). The CHO cells
display R5 and Rv integrins on their surfaces, which interact
with the canonical RGD tripeptide motif present in the matrix
protein ﬁbronectin (Figure 1B).
7 These cells are unable to attach
to the benzenesulfonamide-terminated monolayer (Figure 1C).
To restore adhesion to this monolayer, we designed and
expressed a human carbonic anhydrase IV (hCAIV) protein that
included at its carboxy-terminus a linker and the RGD motif
(CA-RGD) (Figure 1D). Because carbonic anhydrase binds to
benzenesulfonamide ligand with micromolar afﬁnity,
8 we
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Figure 1. CHO cell adhesion to model substrates. (A) Schematic of
benzenesulfonamide-presenting monolayer. (B) CHO cells adhere to RGD-
presenting monolayers, but (C) fail to adhere to benzenesulfonamide
surfaces. (D) CHO cells adhere to benzenesulfonamide surfaces in the
presence of CA-RGD.
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medium would result in its binding to the monolayer and
therefore recruitment of the RGD motif to the surface, where it
could mediate adhesion of the CHO cells. Ternary complex
formation has been shown to be an efﬁcient method of targeting
antibodies to virus-infected cells.
9
Our results demonstrate that cell adhesion to unnatural ligands
can be induced in the presence of the adaptor protein. The
observed cell adhesion phenotype was similar to the one
observed on covalently modiﬁed RGD surfaces, suggesting that
cells can exert the same contractile forces on both substrates.
This work is signiﬁcant as it adds a new method to engineer
cell adhesion. This strategy is widely applicable and of special
interest when surface modiﬁcation or receptor introduction into
a cell is impractical or impossible.
Materials and Methods
CA-RGD Construction and Expression. CA-RGD was ampli-
ﬁed from a previous hCAIV gene with adaptor primers including
NheI and BamHI recognition sequences. The sequence of the
forward primer, including an NheI recognition site followed by the
ﬁrst six codons of hCAIV, was 5′-ATATGCTAGCGCCGGTCTA-
GAGTCACAC-3′. The reverse complementary sequence of the
reverse primer, including a BamHI recognition site followed by
the last ﬁve codons of hCAIV, followed by the codons of the
GGSGGGGSGGRGDS sequence and a stop codon, was 5′-
ATTAGGATCCTTAGCTGTCACCGCGAC-
CACCGCTACCACCACCACCGCTACCACCG-
GACTTTATCACCGT-3′. The polymerase chain reaction (PCR)
consisted of an initial 1 min denaturation at 95 °C, followed by 30
cycles of 1 min 95 °C denaturation, 1 min 55 °C annealing, and
2.5 min of 73 °C extension. After 30 cycles, a ﬁnal extension at
73 °C for 5 min followed by cooling at 4 °C was performed. The
PCR products were cleaved with NheI and BamHI, puriﬁed, and
cloned in frame into the pET-11a vector (Novagen). Insertion of
the hCAIV gene with the C-terminal linker and RGDS sequence
was conﬁrmed by DNA sequencing. For ease of puriﬁcation, a six
His tag was introduced in the N-terminus using a QuikChange
site-directed mutagenesis kit (Stratagene). The forward primer
had the sequence 5′-GATATACATATGGCTAGCCACCAC-
CACCACCACCACGCCGGTCTAGACTCAC-3′. The reverse
primer had the sequence 5′-GTGACTCTAGACCG-
GCGTCGTCGTCGTCGTCGTGGTGGTG-
GTGGGGTGGCTAGCCATATGTATATC-3′. The construct was
ampliﬁed with the cycling parameters suggested in the product,
using 18 cycles. Insertion of the His tag was veriﬁed with DNA
sequencing. The construct was then transformed into Escherichia
coli (strain Origami B DE3) cells for production of CA-RGD
following standard procedures. For protein expression, single
ampicillin-resistant colonies were grown in Luria-Bertani
medium supplemented with 100 mg/mL ampicillin at 37 °C and
190 rpm overnight.A1m Laliquot of this culture was used to
inoculate1Lo fLuria-Bertani medium supplemented with 100
mg/mL ampicillin and grown to an OD600 of 0.6. After induction
with 1 mM isopropyl- -D-thiogalactopyranoside, the cells grew
f o r4ha t3 7°C and 190 rpm. Cultures were then centrifuged
and pellets resuspended in 20 mL of phosphate-buffered saline
(PBS) (10 mM phosphate, 150 mM NaCl, pH 7.0). Cells were
sonicated for 10 min, and the suspension was centrifuged to
remove cellular debris. The supernatant was applied to a TALON
single step (Clontech) and incubated in ice for 30 min. After
initial elution, the column was incubated with 10 mL of buffer
A (25 mM TRIS, 1.5 mM MgCl2, 5 mM NaCl, 1.25% Triton X)
on ice for 30 min. This step was performed twice. After elution,
the column was incubated with 5 mL of buffer B (25 mM TRIS,
1.5 mM MgCl2, 5 mM NaCl, 150 mM imidazole) for 10 min on
ice and eluted. This fraction was concentrated using 10 kDa
Amicon ﬁltration units (Millipore) and extensively dialyzed
against PBS (10 mM phosphate, 150 mM NaCl, pH 7.0) in 10
kDa dialysis cassettes. The purity of the protein was assessed
with sodium dodecyl sulﬁde-polyacrylamide gel electrophoresis;
protein concentration was measured using NanoDrop.
Peptide Synthesis. Ac-GRGDSC, Ac-GGRDGSC, Ac-GRGDS,
and Ac-GGRDGS were synthesized manually following standard
Fmoc peptide synthesis protocols using Fmoc-Rink amide MBHA
resin. All peptides were puriﬁed by reverse-phase high-performance
liquid chromatography using a C18 column (Waters) and character-
ized with matrix-assisted laser desorption/ionization time-of-ﬂight
mass spectrometry (MALDI-TOF MS).
Preparation of Monolayers. Glass coverslips were sonicated
for 30 min in deionized ultraﬁltered (DIUF) water and 30 min in
ethanol and then dried under a stream of nitrogen. Titanium (4 nm)
and then gold (29 nm) were evaporated onto the coverslips using
an electron beam evaporator (Boc Edwards) at a rate of 0.05-0.10
nm/s and at a pressure of 1 µTorr. The gold-coated coverslips were
immersed in an ethanolic solution of either maleimide-terminated
disulﬁde (2%) and tri(ethylene glycol)-terminated disulﬁde (98%)
or amine-terminated disulﬁde (1%) and tri(ethylene glycol)-
terminated disulﬁde (99%) and incubated overnight at room
temperature. The total disulﬁde concentration was 1 mM. The
substrates were washed with DIUF water and ethanol and then dried
under a stream of nitrogen.
Surface Plasmon Resonance. Surface plasmon resonance (SPR)
measurements were performed using 1% benzenesulfonamide
SAMs and CA-RGD following the methods described by Mrksich
et al.
8
Cell Adhesion Assay. Cysteine-terminated peptides were
immobilized onto 1% maleimide-presenting SAMs by immersing
the biochip in 1 mM peptide solution (TRIS buffer, pH 7.5)
and incubating at 37 °C for 1 h. Benzenesulfonamide was
immobilized by immersing a 1% amine-terminated SAM in a 1
mM benzenesulfonamide-NHS solution (1:1 DMSO:100 mM
triethanol amine, pH 7) and incubating at room temperature for
30 min. The reaction was repeated three times to ensure
completion. Substrates were rinsed with DIUF water and ethanol
and dried under a stream of nitrogen. CHO K1 cells were
detached from culture plates with 1 mM ethylene glycol bis(2-
aminoethyl ether)-N,N,N′,N′-tetraacetic acid (EGTA)/2 mM
ethylenediaminetetraacetic acid (EDTA) in PBS, rinsed with
F-12K medium (10% fetal bovine serum (FBS), 1X penicillin/
streptomycin), centrifuged, and resuspended in the same medium
at a density of 60 000/mL. Cells were added to substrates in
24-well culture plates. For 1% benzenesulfonamide substrates,
the cell suspension was supplemented with 10 µM CA-RGD.
Cells were incubated at 37 °C and 5% CO2 for 4 h. Upon
completion of the incubation period, substrates were gently
washed with warm PBS and imaged with a 20× objective of a
Zeiss Axiovert 200 inverted microscope.
Immunostaining. CHO K1 cells were allowed to adhere and
spread on substrates as described above. Substrates were washed
gently with PBS, and permeabilized with 4% formaldehyde and
0.5% Triton-X for 30 min. Fixed and permeabilized cells were
blocked in the presence of blocking buffer (1% bovine serum
albumin, 5% goat serum, and 0.1% Triton-X) for 30 min. Substrates
were then incubated with 1:1000 dilution of monoclonal antivinculin
immunoglobin (IgG) (Sigma) for 30 min, followed by incubation
with 1:400 dilution of phalloidin-AF488 and TR goat antimouse
IgG and 1:5000 4′,6-diamidino-2-phenylindole (DAPI) for 30 min.
After washing extensively with blocking buffer, the substrates were
mounted with Aqua Poly/Mount (PolySciences Inc.). Fluorescent
images of cells on substrates were acquired with a 100× objective
of a Zeiss Axiovert 200 inverted microscope.
(8) Mrksich, M.; Grunwell, J. R.; Whitesides, G. M. J. Am. Chem. Soc.
1995, 117, 12009–12010.
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Chem. Soc. 2009, 131, 16392–16394.
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CA-RGD. Benzenesulfonamide was immobilized by immersing a
1% amine-terminated SAM ina1m Mbenzenesulfonamide-NHS
solution (1:1 DMSO:100 mM triethanol amine, pH 7) and incubat-
ing at room temperature for 30 min. The reaction was repeated
three times to ensure completion. Substrates were rinsed with DIUF
water and ethanol and dried under a stream of nitrogen. CHO K1
cells were detached from culture plates with 1 mM EGTA/2 mM
EDTA in PBS, rinsed with F-12K medium (10% FBS, 1X
penicillin/streptomycin), centrifuged, and resuspended in the same
medium at a density of 60 000/mL. Cells were added to substrates
in 24-well culture plates with different concentrations of CA-RGD.
Cells were incubated with at 37 °C and 5% CO2 for 4 h, followed
by a gentle PBS wash. Adherent cells were immediately ﬁxed and
permeabilized with 4% formaldehyde and 0.5% Triton-X for 30
min. Fixed and permeabilized cells were stained with DAPI (1:
5000) for 30 min and mounted with Aqua Poly/Mount (Poly-
Sciences Inc.). Fluorescent images of cells’ nuclei on substrates
were acquired with a 20× objective of a Zeiss Axiovert 200 inverted
microscope. The number of adherent cells per ﬁeld of view was
counted using Image J. Cells were counted in at least ﬁve ﬁelds
for each substrate, and each experiment was repeated three times.
Adhesion is reported as the average count of nuclei per ﬁeld of
view, using the standard error for error bars.
Cell Adhesion Inhibition Assay. Suspensions of CHO K1 cells
(60 000/mL) were incubated with soluble inhibitors (Ac-GRGDS,
Ac-GGRDGS, and benzenesulfonamide) for 10 min prior to addition
to benzenesulfonamide substrates (in the presence of CA-RGD).
Cells were incubated as described in the cell adhesion assay. After
incubation, the substrates were washed gently with warm PBS, and
adherent cells were immediately ﬁxed and permeabilized with 4%
formaldehyde and 0.5% Triton-X for 30 min. Fixed and perme-
abilized cells were stained with DAPI (1:5000) for 30 min and
mounted with Aqua Poly/Mount (PolySciences Inc.). Fluorescent
images of cells’ nuclei on substrates were acquired with a 20×
objective of a Zeiss Axiovert 200 inverted microscope. The number
of adherent cells per ﬁeld of view was counted using Image J. Cells
were counted in at least ﬁve ﬁelds for each substrate, and each
experiment was repeated three times. The degree of inhibition is
reported as a percentage of cells that adhere relative to control
experiments in the absence of soluble inhibitor. Standard error was
used for error bars.
Results
CA-RGD Expression and Binding. The adaptor protein CA-
RGD is composed of carbonic anhydrase IV (CAIV) followed
by a linker, GGSGGGGSGG. The C terminal of the linker is
terminated with an RGDS peptide that promotes cell adhesion.
A His tag was introduced in the N terminal of the CAIV segment
for ease of puriﬁcation (Figure 2A). The binding of CA-RGD
was characterized using SPR. SPR experiments demonstrated
that CA-RGD binds to 1% benzenesulfonamide SAMs and fails
to bind to 100% ethylene glycol SAMs (Figure 2B). These
experiments showed that the expressed protein is active and
that it binds selectively to benzenesulfonamide substrates.
CA-RGD Mediates Chinese Hamster Ovary Cell Adhesion
and Cytoskeletal Structure Comparable to Ac-GRGDSC. We
next examined if CA-RGD was capable of mediating CHO cell
adhesion to benzenesulfonamide SAMs. As a control, we also
seeded CHO cells on 1% Ac-GRGDSC substrates, onto which
the RGD peptide had been covalently immobilized. CHO cells
failed to adhere to 1% benzenesulfonamide substrates (Figure
3B). When the experiment was repeated using medium that was
supplemented with CA-RGD (10 µM), the cells attached to the
monolayer and assumed a well-spread morphology (Figure 3C).
The cells were indistinguishable from those that attached to a
control monolayer that directly presented the RGD peptide
ligand (Figure 3D). We ﬁxed and stained the adherent cells with
phalloidin to visualize the actin stress ﬁlaments and with an
anti-vinculin antibody to visualize the focal adhesions. For both
surfaces, cells had well-developed cytoskeletal structures (Figure
3E,F). Several control experiments establish the speciﬁcity of
Figure 2. CA-RGD expression and binding to a benzenesulfonamide-
presenting monolayer. (A) Primary structure of CA-RGD. His tag shown
in bold, CAIV shown underlined, linker shown in italics, RGD domain
shown in red. (B) SPR sensorgrams show that CA-RGD binds to 1%
benzenesulfonamide SAMs but fails to bind to 100% tri(ethylene glycol)
SAMs.
Figure 3. CHO cell adhesion and cytoskeletal structure mediated by CA-
RGD on 1% benzenesulfonamide substrates (C,E) and 1% Ac-GRGDSC
substrates (D,F). Cells failed to adhere to benzenesulfonamide monolayers
(B).
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example, CHO cells failed to adhere to monolayers presenting
only tri(ethylene glycol) groups or the scrambled peptide Ac-
GGRDGS (data not shown). Further, adhesion to the benzene-
sulfonamide-terminated monolayer in the presence of the adaptor
protein could be inhibited by adding either bovine carbonic
anhydrase or benzenesulfonamide ligand to the medium (data
not shown).
CA-RGD-Mediated Cell Adhesion Is Concentration
Dependent. The adaptor protein CA-RGD has a bivalent
character, as it contains a domain that binds to cells and another
that binds to the surface. Hence, the adaptor protein has the
capacity to form a ternary complex with cells and the surface,
or to bind to each independently. This dual character allows
CA-RGD to either mediate adhesion or inhibit the adhesion of
the cells. Because these roles should show a dependence on
the concentration of protein, we compared the adhesion of CHO
cells to monolayers presenting the benzenesulfonamide ligand
with concentrations of the adaptor protein CA-RGD ranging
from 0.1 to 100 µM (Figure 4). We found that the number of
cells that attached increased with the concentration of the adaptor
protein, reached a maximum at 10 µM, and then decreased with
higher concentrations of protein. This trend is consistent with
the bifunctional nature of the adaptor protein, since lower
concentrations of protein should favor the equilibrium for
binding of the protein to both the integrin and the benzene-
sulfonamide in a ternary complex, but higher protein concentra-
tion led to partitioning of the adaptor construct into binary
complexes that would abrogate cell adhesion.
CA-RGD-Mediated Cell Adhesion Is Speciﬁc. As noted
above, we found that both soluble RGD peptide and benzene-
sulfonamide ligand showed a dose-dependent inhibition of
adaptor protein-mediated cell adhesion to the benezensulfona-
mide-terminated monolayer, with 50% inhibition occurring at
inhibitor concentrations near 10 µM. Again, as evidence of the
speciﬁcity of these interactions, the scrambled peptide GGRDGS
had no effect on cell adhesion at any concentration tested (Figure
5A). We investigated the inhibition of adhesion by mixtures
containing both the RGD peptide and the CA ligand, and we
found that the mixture was more effective at blocking adhesion
than was either ligand alone. Indeed, using mixtures that had
different ratios of the two ligandssbut always at a total
concentration of 10 µMswe found that the strongest inhibition
was observed when the ligands were present in a 1:1 ratio
(Figure 5B).
Discussion
In this paper we report the use of an adaptor protein to restore
cell adhesion to substrates that otherwise do not present ligands
for the integrin receptors. We used a bifunctional protein that
that can simultaneously bind to a benzenesulfonamide ligand
immobilized to a monolayer substrate and to a cell-surface
integrin receptor on CHO cells. The bifunctional protein, CA-
RGD, was effective in restoring cell adhesion to the monolayers
and gave cell morphologies that were similar to those observed
for cells adherent to an RGD-presenting monolayer. Hence, cells
that were tethered to the surface by way of a noncovalently
immobilized RGD ligand could still display normal cell adhesion
and contractile cytoskeletal structures. The CA-RGD adaptor
protein mediated speciﬁc adhesion, as shown by the ability of
a soluble benzenesulfonamide ligand or RGD peptide to block
adhesion. The most signiﬁcant result is the demonstration that
reversibly immobilized adhesion ligands can support the adhe-
sion of cells.
The CA-benzenesulfonamide complex undergoes dissocia-
tion with a rate constant on the order of 1-10 s-1. However,
theadhesionofcellsengagesalargenumberofCA-benzenesulfonamide
complexes, and this polyvalent scaffold of interactions signiﬁ-
cantly increases the avidity of the complexes and consequently
maintains a stable engagement of the cell with the surface.
Mechanistic studies of polyvalent complexes have revealed them
to be extraordinarily stable, often mediating binding events
comparable to irreversibly bound ligands.
10,11 This stability
derives from the improbability that each of the individual
interactions is simultaneously in the dissociated state, which
would be required for dissociation of the complex. Thus,
although the CA-benzenesulfonamide interaction has a lifetime
that is short relative to the time scale for cell adhesion, a
threshold number of ligand-receptor bonds are maintained on
average and able to support cell adhesion and spreading. Again,
it is signiﬁcant that the observed adhesion was comparable to
that observed for substrates having a covalently immobilized
RGD.
We note previous work that has used bimolecular complexes
to immobilize adhesion ligands for promoting cell adhesion.
(10) Mammen, M.; Choi, S.-K.; Whitesides, G. M. Angew. Chem., Int. Ed.
1998, 37, 2754–2794.
(11) Vance, D.; Martin, J.; Patke, S.; Kane, R. S. AdV. Drug DeliVery ReV.
2009, 61, 931–939.
Figure 4. CA-RGD-mediated CHO cell adhesion depends on protein
concentration. Error bars are the standard error of three experiments.
Figure 5. Characterization of CHO cell adhesion to CA-RGD on 1%
benzenesulfonamide substrates. (A) Inhibition of cell adhesion in model
system using soluble inhibitors. (B) Mixed inhibition of benzenesulfonamide
and RGD peptide on CA-RGD-mediated cell adhesion. Error bars are the
standard error of three experiments.
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labeled RGD peptide to tissue culture plastic that was coated
with a layer of streptavidin.
12,13 The resulting surfaces supported
robustcelladhesion,butinthiscasetheuseofastreptavidin-biotin
interaction provided for an essentially irreversible presentation
of the RGD peptide and, in that sense, is more analogous to a
covalent immobilization of ligands on a surface. By using a
CA-benzenesulfonamide interaction to immobilize the RGD,
we use an interaction that is rapidly reversible over the time
scale of an adhesion experiment. We believe that this report is
the ﬁrst that localizes cell adhesion ligands to a surface in a
reversible manner.
As discussed earlier, polyvalent systems combine two con-
tradictory properties: they can associate to give an irreversible
complex, but they can also be rapidly dissociated in the presence
of a soluble ligand. We suggest that this property may enable
a class of dynamic surfaces that can be used to change the
identity of the immobilized ligand or remove the ligand
completely and thereby release cells from the substrate. For
example, by adding to the medium a fusion protein that binds
the monolayer but that is modiﬁed with a second adhesion
ligand, this protein is expected to exchange with the proteins
that mediate adhesion and be driven by equilibrium to change
the composition of adaptor protein at the cell-substrate
interface. Similarly, a protein that can bind the substrate but
that does not include an adhesion ligand may be useful for
“removing” the RGD ligand and thereby releasing a cell culture
without the need for enzyme treatment (as is now common and
which can lead to unwanted proteolysis of cell-surface recep-
tors).
Finally, we recognize the possibility of using this strategy to
induce cell adhesion where the covalent introduction of cell
adhesion ligands is not straightforward, particularly in in ViVo
settings. Many blistering diseases, for example, are associated
with mutations that compromise the adhesion activity of
extracellular matrix proteins.
14 Adaptor proteins that are de-
signed to include a domain that binds to the mutated protein
and a domain that binds to cells might represent a therapeutic
solution for rescuing cell adhesion and stabilizing the tissue
interface that is compromised in these diseases. This strategy
is distinct from those under investigation that are based on
protein injection and gene therapy
5,15 in that it involves an
adaptor protein that would form a polyvalent scaffold at the
site of injury and alleviate blistering symptoms, rather than the
introduction of a native protein.
This report also illustrates the applicability of SAM substrates
as mimics of the extracellular matrix.
2 The monolayers allow
excellent control in orientations, densities, and compositions of
immobilized ligands, whereas tri(ethylene glycol)-terminated
monolayers are among the most effective at minimizing the
nonspeciﬁc adsorption of protein. The combination of these
beneﬁts allows the molecular interactions between a cell and
its substrate to be controlled. Finally, the monolayers can be
directly characterized with MALDI-TOF MS and therefore can
be structurally checked. In this work, we used SAMs to present
the benzenesulfonamide moiety against an inert background,
facilitating the speciﬁc recruitment of CA-RGD to the surface
and the subsequent speciﬁc cell adhesion.
Conclusion
This work demonstrates the use of an exogenous protein to
restore cell adhesion to a material that otherwise does not
support adhesion. This engineering modality adds to the elegant
strategies that have been demonstrated for biosynthetically
modifying the cell surface or the surfaces of materials to
introduce complementary interactions that mediate adhesion.
4,16,17
The present strategy is signiﬁcant in that it does not require
either the introduction of receptors in the cell or the modiﬁcation
of substrate with cell adhesion ligands, and therefore it may be
applicable for creating surfaces that can be dynamically remod-
eled with different adhesion motifs and for repairing the loss
of cell adhesion to mutated proteins in ViVo. In the analogous
use of soluble ligands to inhibit the adhesion of cells, for
example, the monomeric ligands are far less effective than are
corresponding multivalent ligands.
18 In this sense, the present
work demonstrates a strategy for the self-assembly of a
polyvalent scaffold from monomeric building blocks and
suggests that this strategy may ﬁnd broader use in the design
and application of polyvalent ligands.
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